Common Lipid-Lowering Drug May Slow Diabetic Eye Damage

A common lipid-lowering drug is tied to markedly lower odds of vision-threatening retinopathy, cataracts, and macular edema in patients with mild or moderate nonproliferative diabetic retinopathy.
Medscape Medical News